Claim Missing Document
Check
Articles

Found 39 Documents
Search

Profile of Pulmonary Tuberculosis Patients with Type 2 Diabetes Mellitus in Pulmonary Department Dr. Soetomo General Hospital Surabaya Ayu Rahmanita Putri Soetrisno; Rebekah Juniati Setiabudi; Laksmi Wulandari
Jurnal Respirasi Vol. 6 No. 2 (2020): May 2020
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (185.181 KB) | DOI: 10.20473/jr.v6-I.2.2020.35-39

Abstract

Background: Pulmonary tuberculosis (TB) is the most important infectious disease, caused by Mycobacterium tuberculosis (MTB). Indonesia is the third country with the most prevalent TB cases in the world. Not all people who were exposed to MTB will become active TB, because the immune response is the main determinant. Immunocompromised person, such as patients who have type 2 diabetes mellitus (DM) as a comorbid are more prone to develop active TB infection. This study aimed to analyze the profile of pulmonary TB patients with type 2 DM in Pulmonary Department Dr. Soetomo General Hospital Surabaya.Methods: This was an observational descriptive study with a cross-sectional design. The research data were obtained from the medical records of TB patients with type 2 DM in Pulmonary Department Dr. Soetomo General Hospital Surabaya in January - December 2017.Results: Out of a total of 414 hospitalized patients, 74 patients with pulmonary TB were found with type 2 DM. Only 53 patients fulfilled the inclusion criteria. Gene Xpert results were sensitive (66.7%), previous TB treatment history (54.7%), unregulated type 2 DM (88.4%), RBG with the average of 311.83 mg/dl, PPBS with the average of 263.31 mg/dl, FBG with the average of 238 mg/dl, and HbA1C > 10% (68%).Conclusion: The majority of the patients of pulmonary TB with type 2 DM have average high blood glucose and unregulated DM.
Problem Penegakkan Diagnostik Pasien dengan Massa di Paru: [Diagnostic Problems in Lung Mass Management] Laksmi Wulandari; Nikson Eduard Faot
Jurnal Respirasi Vol. 3 No. 2 (2017): Mei 2017
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (977.856 KB) | DOI: 10.20473/jr.v3-I.2.2017.41-46

Abstract

Background: Lung cancer are divided into 2 groups; i.e. Small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). About 30% of NSCLC is squamus cell carcinoma and the other is adeno carcinoma. Late diagnosis makes such a high mortality rate. Early diagnosis plays a very important role in the management of therapy. Case: Patients complain of chronic cough more than 6 months, decreased appetite and weight loss. Chest X-ray and CT scan show a density of round shape mass, with firm border and smooth regular edge, also lympnodes enlargement (T2N2Mx) stage IIb. Appearance of lung mass is benign according to clinically and radiologically. FNAB-CT Guiding results are difference each time examination. The first result is squamous cell carcinoma but the last result is teratoma. Discussion: Based on the multidisciplinary discussion on Tumor Board Meeting, the diagnosis was decide as Squamous cell Carcinoma. The choice management of stage IIb lung cancer is surgery (Lobectomy). Histopathology finding post surgery is a Squamus Cell Carcinoma. Patients were then given adjuvant chemotherapy for 4 cycles with Platinum Base regimen paxuscarboplatin with the aim of clearing micrometastase that may still be left behind. The complete respons of platinum based chemotherapy following surgery in early stage of squamous cell carcinoma. Conclusion: Difficulties of lung cancer diagnostic are still the problem in the management of lung mass. Difference of diagnostic makes difference treatment choice. Multidiscipline discussion is needed to decide the diagnostic and treatment judgment.
Terapi ARV pada Penderita Ko-Infeksi TB-HIV: [Antiretroviral Therapy in TB-HIV Co-Infection Patient] Indana Eva Ajmala; Laksmi Wulandari
Jurnal Respirasi Vol. 1 No. 1 (2015): Januari 2015
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (406.585 KB) | DOI: 10.20473/jr.v1-I.1.2015.22-28

Abstract

TB and HIV have a very close relationship since the development of AIDS. Through a significant reduction in cellular immunity, HIV affects the pathogenesis of tuberculosis, thereby increasing the risk of TB in HIV co-infected individuals. In 2006, there were an estimated 9.2 million new TB cases worldwide, there were 710.00 in patients with HIV and 500,000 cases with MDR-TB. Sensitivity to TB associated with cytokine production by T lymphocytes (IFN gamma and TNF are like alpha). During HIV infection, IFN gamma production declined dramatically in line with the decrease in CD4 T lymphocytes This leads to an increased risk of developing reactivation or reinfection Mycobacterium tuberculosis. Clinical symptoms of pulmonary TB in people living with HIV are often non-specific. Clinical symptoms often found are fever and significant weight loss. The other symptoms usually associated with extrapulmonary TB. Antiretrovirals are drugs that inhibit HIV replication. The main priority in patients co-infected with TB-HIV is a start of TB therapy, followed by cotrimoxazole and ARV. ARV treatment recommendation on co-infection tuberculosis is starting ARV therapy to all people living with HIV with active TB, regardless of CD4 cell count. Antiretroviral therapy start as soon as possible after TB treatment can be tolerated, as soon as 2 weeks and no more than 8 weeks. Regimen set by WHO for first-line regimen containing two nucleoside reverse transcriptase inhibitors (NRTIs) plus one non-nucleoside reverse transcriptase inhibitors (NNRTIs). In the co-infection of TB-HIV nucleoside was elected WHO recommended Zidovudine (AZT) or tenofovir disoproxil fumarate (TDF), in combination with lamivudine (3TC) or emricitabine (FTC). For NNRTI, WHO recommends efavirenz (EFV) or nevirapine (NVP).
Tumor Mediastinum Anterior (Yolk Sac Tumor) pada Seorang Laki-Laki Dewasa Muda: Sebuah Kasus yang Jarang: [Yolk Sac Tumor in a Young Man: A Rare Case] Risnawati Risnawati; Laksmi Wulandari
Jurnal Respirasi Vol. 2 No. 2 (2016): Mei 2016
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (944.996 KB) | DOI: 10.20473/jr.v2-I.2.2016.45-51

Abstract

Background: Primary mediastinal yolk sac tumor is an extremely rare and highly malignant tumors occuring in children and young adult. They are more common in men. The most common symptoms on ptesentation were dyspnea, chest pain, cought, fever, night sweat, or weight loss. Primary mediastinal tumor are considered to have poor prognosis. Case: A 18- year-old man who presented with shorthness of breath, chest pain, fever, night sweat, and generalized weakness. He had no significant surgical, familiy or social history. The chest X-Ray and computed tomographic scan of the chest showed a large anterior mediasti nal mass. The serum level of alpha- fetoprotein and β-HCG was elevated. The histological examination revealed the finding of yolk sac tumor. This supported the diagnosis of yolk sac tumor. The patient received a combination chemotherapy consisting of cisplatin, etoposide and bleomycin every 3 weeks for total of 4 cycles. Conclusions: Primary mediastinal yolk sac tumor is a rare tumor. The diagnosis should be made not only by morphological studies but the also the patients age and the elevation of serum alpha-fetoprotein. In spite of modern chemotherapy, the prognosis of mediastinal yolk sac tumor remains poor.
Hemoptisis pada Pasien Aspergilloma Paru Kiri: [Hemoptysis in Aspergiloma Patient: A Case Report] Gilang Muhammad Setyo Nugroho; Laksmi Wulandari
Jurnal Respirasi Vol. 4 No. 2 (2018): Mei 2018
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (812.603 KB) | DOI: 10.20473/jr.v4-I.2.2018.38-44

Abstract

Background: Aspergilloma is a fungus ball (misetoma) that occurs because there is a cavity in the parenchyma due to previous lung disease. This fungus ball can move inside the cavity but does not invate the cavity wall. The presence of fungus ball causes recurrent hemoptysis. Case: We present a 45-year-old female patient with left lung Aspergilloma. Diagnosis of Aspergilloma was based on histopathology from FNAB CT guiding of left pulmonary which showed Aspergillus. Patient was treated with left superior lobe lobectomy at the hospital. The examination result of anatomical patology obtained from lung tissue was aspergillosis, from GeneXpert examination lung tissue showed positive MTB with rifampisin sensitive. Post-operative condition of the patient was stable, surgical wound improved, took off drain patient. There were clinical improvements after the surgery. Discussion: Diagnosis of Aspergilloma was based on clinical, radiology, and microbiology. Aspergilloma with severe symptoms (hemoptysis massive with life-threatening or other complications that require more than 1 time hospitalisation) and good physical condition should undergo surgical therapy in the form of lobectomy in accordance with the extent of lung abnormalities. Patient got first category anti tuberculosis drugs for 6 months and fluconazole for 2 months. Conclusion: It is necessary to consider the suspicion of Aspergillus infection, in patient with history of previous tuberculosis accompanied by a history of recurrent hemoptysis. Patient with reccurent hemoptysis and good physical condition should undergo surgical therapy.
PENATALAKSANAAN TUBERKULOSIS SECARA HOLISTIK MELALUI PENDEKATAN KEDOKTERAN KELUARGA Utami Meilanie Putri; Evelyn Asaleo; Veda Septian Cahya Budi; Khansa Fahira Wisdana; Laksmi Wulandari
Jurnal Perak Malahayati Vol 4, No 2 (2022): Vol 4 No 2 November 2022
Publisher : Program Studi Kebidanan Fakultas Kedokteran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33024/jpm.v4i2.8503

Abstract

Latar Belakang: Mycobacterium tuberculosis adalah bakteri yang menyebabkan penyakit tuberkulosis. Penularan penyakit ini terjadi melalui penyebaran aerosol dari penderita TB yang dapat terjadi ketika berbicara, bersin, batuk, dan lainnya. Gejala klinis yang umum ditemukan pada orang dengan TB diantaranya adalah batuk kronis, batuk darah, penurunan berat badan, demam dan keringat malam.  Keterlambatan pengobatan pada pasien TB dapat menyebabkan peningkatan mortalitas dan penularan penyakit yang lebih luas. Berdasarkan kondisi tersebut sangat penting untuk melakukan deteksi dan pengobatan secara dini sebagai tindakan pencegahan penularan dan mortalitas.Tujuan: Mengaplikasikan pelayanan kesehatan melalui program kedokteran keluarga secara holistik.Metode: Penyuluhan dilakukan dengan melalui proses anamnesis, pemeriksaan fisik, pemeriksaan keluarga, dan pemeriksaan fisik melalui kunjungan ke rumah pasien. Kemudian dilakukan diagnosis, tatalaksana, dan edukasi mengenai TB serta etika batuk dan buang dahak kepada pasien dan keluarga pasien.Hasil: Kegiatan dilakukan di rumah Tn.S, laki-laki, 34 tahun, mengeluhkan sesak sejak 1 tahun yang lalu, sesak didahului batuk sejak 2 bulan sebelumnya. Pasien didiagnosis menderita TB setelah dilakukan tes sputum dan didapatkan hasil positif TB. Penatalaksanaan diberikan kepada pasien bersifat komprehensif dan holistik berdasarkan 5 aspek, yakni aspek personal, klinis, risiko internal, risiko eksternal, dan derajat fungsional. Tindakan selanjutnya yang kami lakukan adalah intervensi. Intervensi terdiri dari intervensi promotif, preventif, kuratif, rehabilitatif, serta advokasi dan kajian pembiayaan, sehingga tatalaksana diberikan secara komprehensif dan holistik.Kesimpulan: Hasil kunjungan rumah didapatkan pasien dan keluarga mengerti dan menerima edukasi serta konseling yang diberikan.
PENYULUHAN PENATALAKSANA ASMA SECARA HOLISTIK Zaphiria Loka Pramesthi; Grahana Ade Candra Wolayan; Muhammad Fitra Ramadhan; Arta Rahman; Zahira Pelangi Rahmadilla Satriadi; Laksmi Wulandari
Jurnal Perak Malahayati Vol 4, No 2 (2022): Vol 4 No 2 November 2022
Publisher : Program Studi Kebidanan Fakultas Kedokteran

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33024/jpm.v4i2.8487

Abstract

ABSTRAK Latar Belakang: Asma adalah penyakit saluran pernapasan yang umum dan memiliki berbagai tingkat keparahan, mulai dari mengi yang sangat ringan hingga penutupan saluran napas akut yang mengancam jiwa. Asma merupakan masalah kesehatan yang serius karena dapat menurunkan kualitas hidup penderita. Maka dari itu, diperlukan tatalaksana yang holistik dan komprehensif agar asma terkontrol dengan gangguan yang sangat minimal dapat tercapai.Tujuan: Mengaplikasilan pelayanan kesehatan melalui program kedokteran keluarga secara holistik.Metode: Penyuluhan dilakukan dengan melalui proses anamnesis, pemeriksaan fisik, pemeriksaan keluarga, dan pemeriksaan fisik melalui kunjungan ke rumah pasien. Kemudian dilakukan diagnosis, tatalaksana, dan edukasi kepada pasien dan keluarga yang berjumlah 8 orang.Hasil: Kegiatan dilakukan di rumah Ny. S, perempuan, 45 tahun, mengeluhkan sesak napas sejak 2 hari yang lalu di pagi hari, sesak didahului batuk dan mengi. Pasien didiagnosis asma persisten ringan terkontrol sebagian. Penatalaksanaan diberikan kepada pasien bersifat komprehensif dan holistik berdasarkan 5 aspek, yakni aspek personal, klinis, risiko internal, risiko eksternal, dan derajat fungsional. Tindakan selanjutnya yang kami lakukan adalah intervensi. Intervensi terdiri dari intervensi promotif, preventif, kuratif, rehabilitative, serta advokasi dan kajian pembiayaan, sehingga tatalaksana diberikan secara komprehensif dan holistik.Kesimpulan: Hasil kunjungan rumah didapatkan pasien dan keluarga mengerti dan menerima edukasi serta konseling yang diberikan.    Kata Kunci: Asma, Kedokteran Keluarga
The effects of age on antibody response towards COVID-19 vaccination: A Systematic Review Hendra Ikhwan Gautama; Gatot Soegiarto; Laksmi Wulandari
JUMANTIK (Jurnal Ilmiah Penelitian Kesehatan) Vol 8, No 1 (2023)
Publisher : Prodi Kesehatan Masyarakat Fakultas Kesehatan Masyarakat UIN Sumatera Utara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30829/jumantik.v8i1.13631

Abstract

Background: Mortality rate of COVID-19 infection isexceptionally high in the older population. Various vaccines are being rapidly developed as an attempt to halt the pandemic. Although vaccination has been effective in reducing mortality and hospitalization rate in recent months, lower vaccine effectiveness has been reported among older adults.Aim: This review aims to evaluate and summarize current evidence on the effect of age on antibody response towards COVID-19 vaccines. Methods: Literature search was conducted on PubMed, Scopus, ScienceDirect and ProQuest for studies published up to 9th October 2022. The selected studies were assessed The Joanna Briggs critical appraisal tools. Qualitative analysis was then performed for the final studies.Result: A final of 9 studies were included in this review. A majority of the studies evaluated the responses of BNT162b2 or mRNA-1273 vaccine, while 1 study investigated the response towards ChAdOx1 vaccine. Outcomes were measured in term of IgG antibody levels or serum neutralization. Most studies demonstrated significantly lower antibody response and neutralization in older adults compared to younger vaccinees after administration of first and second vaccine dose. However, two studies reported no significant difference in vaccine responses across age groups after third dose administration.Conclusion: This systematic review highlights lowerimmunogenicity towards COVID-19 vaccines in older population. Further research into strategies to improve vaccine responses in the elderly is required to provide sufficient protection for this vulnerable group. Keywords: COVID-19 vaccine, antibody, neutralization, age, elderly
Evaluasi Efikasi Vaksin Covid-19 pada Sumber Daya Manusia Kesehatan Gatot Soegiarto; Laksmi Wulandari; Dewajani Purnomosari3; Delvac Oceandy
Jurnal Keperawatan Vol 14 No 3 (2022): Jurnal Keperawatan: September 2022
Publisher : Sekolah Tinggi Ilmu Kesehatan Kendal

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (404.248 KB)

Abstract

Sejak WHO mengumumkan COVID-19 menjadi pandemic global, kasus infeksi COVID-19 di Indonesia telah menembus angka 1 juta kasus dengan angka kematian hampir 30 ribu kasus. Hingga saat ini masih belum ada terapi definitif untuk infeksi COVID-19, maka vaksinasi diharapkan menjadi tindakan preventif untuk menekan angka morbiditas dan mortalitas. Di Indonesia program vaksinasi menggunakan virus yang tidak aktif telah dilaksanakan pertama kali pada tanggal 13 Januari 2021 dengan sasaran pertama pada tenaga kesehatan. Penelitian ini bertujuan untuk mengevaluasi efikasi vaksin COVID-19 bagi sumber daya manusia kesehatan (SDMK) di RSUD Dr. Soetomo Surabaya. Penelitian ini menggunakan desain studi kohort prospektif dengan total sampel 101 sumber daya manusia kesehatan di RSUD Dr. Soetomo Surabaya yang diperoleh melalui metode consecutive sampling. Semua peserta melakukan wawancara sebelum mendapatkan vaksin dosis pertama untuk mengumpulkan data demografi serta riwayat penyakit penyerta. Selanjutnya semua peserta melakukan pengambilan darah sebanyak 10cc untuk pemeriksaan antibodi terhadap SARS-CoV-2, darah lengkap, laju endap darah, dan HbA1c (bagi yang menderita diabetes mellitus). Pengambilan darah dilakukan sebelum pemberian vaksin dosis pertama, kemudian 1, 3, dan 5 bulan setelah vaksinasi dosis kedua sebagai tindak lanjut. Interval pemberian vaksin antara dosis pertama dan kedua adalah 14-28 hari. Pada penelitian ini, kami menemukan bahwa kadar serum IgG meningkat secara signifikan pada 1 bulan pasca-vaksinasi virus SARS-CoV-2 tidak aktif dosis kedua, namun mulai menurun pada 3 dan 5 bulan pasca-vaksinasi. Data kami memberikan bukti tentang adanya pengaruh faktor demografis, yaitu usia dan riwayat penyakit penyerta, yaitu hipertensi pada respons antibodi terhadap vaksin virus SARS-CoV-2 yang tidak aktif.
Indonesian Society of Respirology (ISR) Consensus Statement on Lung Cancer Screening and Early Detection in Indonesia Sita Andarini; Elisna Syahruddin; Nathaniel Aditya; Jamal Zaini; Ferry Dwi Kurniawan; Sabrina Ermayanti; Noni Novisari Soeroso; Sri Melati Munir; Andreas Infianto; Ana Rima; Ungky Agus Setyawan; Laksmi Wulandari; Haryati Haryati; Ida Ayu Jasminarti; Arif Santoso
Jurnal Respirologi Indonesia Vol 43, No 2 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i2.455

Abstract

Lung cancer is the leading cause of mortality for all cancer globally and in Indonesia. In Indonesia, lung cancer contributes to 12.6% of death of all cancer, making it the number one cause of cancer death, and 8.6% of all cancer incidence in 2018, behind breast, cervical, and colorectal cancer. The total cases per year are expected to almost double from 30,023 in 2018 to 54,983 cases in 2040. Smoking is among the risk factors for lung cancer, after occupational/environmental risk factors, history of lung fibrosis, and family history of cancer. There was a tendency of younger smokers in Indonesia and increased lung cancer incidence and prevalence in the younger population. The median age of lung cancer in Indonesia was younger than in any country, probably due to the younger age of smoking, early onset of carcinogens, asbestos use, and environmental. Lung cancer screening is a voluntary measure to detect lung cancer in the earliest stage, to find cancer at curable disease before symptoms appear in high-risk individuals. Lung cancer early detection is strategies to find cancer earlier after symptoms appear (cough, hemoptysis, dyspnea, chest pain). Low-dose computerized tomography of the thorax (LDCT) screening has been known to reduce lung cancer mortality compared to a chest x-ray (CXR). This Indonesian Society of Respirology consensus statement was aimed to give recommendations on lung cancer screening and early diagnosis in Indonesia.
Co-Authors Agustinus Rizki Aldise M Nastri Aldise Mareta Nastri Aldise Mareta, Aldise Ana Rima Ana Rima Setijadi Ananda, Fannie Rizki Andarini, Sita Andreas Infianto Anna Febriani Apriyanto, Yudi Arfiansyah, Mochammad Aris Arif Santoso Arif Santoso Ariobimo, Bonfilio Neltio Aris Widayati Arta Rahman Aryati Aryati Atik, Nurul Ayu Rahmanita Putri Soetrisno Cita Rosita Sigit Prakoeswa Dana Hendrawan Putra Delvac Oceandy Dewajani Purnomosari, Dewajani Dewajani Purnomosari3 Dewi, Gusti Agung Ayu Ira Kencana Djoko Poetranto, Djoko Duyen, Natalie Edith Frederika, Edith Elisna Syahruddin Emmanuel Djoko Poetranto Ermayanti, Sabrina Ermayanti, Sabrina Erwin Winaya Evelyn Asaleo Fahmita, Karin Dhia Farahannisaa, Kintan Adelia Febriani, Anna Ferry Dwi Kurniawan Gatot Soegiarto Gemilang Khusnurrokhman Gilang Muhammad Setyo Nugroho Grahana Ade Candra Wolayan Hamidah, Berliana Hanif, Muhammad Alfin Hariputri, Wulan Rahmawati Haryati Haryati Haryati Haryati Hendra Ikhwan Gautama Hidayat, Moulid Husniyah, Barizatul Ida Ayu Jasminarti Ida Ayu Jasminarti Dwi Kusumawardani Indana Eva Ajmala Infianto, Andreas Jasminarti, Ida Ayu Juwita, Putri Mega Kazufumi Shimizu Khansa Fahira Wisdana Kinanthi, Monica Tiara Arum Kurniawan, Ferry Dwi Kusdiantoro Kusdiantoro Kusdiantoro Kusdiantoro Landia Setiawati Lim, Darren Wan-Teck Linda Dewanti Lucia Landia Setyowati, Lucia Landia Luh Ade Wilan Krisna Lukisiari Agustini Lusida, Michael AP. Mahdi, Bagus Aulia Maqnun, Lu'lu'il Masaoki Yamaoka Masaoki Yamaoka, Masaoki Muhammad Amin Muhammad Dany Ramadhan Muhammad Fitra Ramadhan Nadira Putri Nastiti Nathaniel Aditya Neni Daniati Nikson Eduard Faot Nina Mauthia Noni Novisari Soeroso Novananda, Donny Ardika Novita Andayani, Novita Pakpahan, Cennikon Paladan, Triadi Putra Pradhevi, Lukita Pratama, Avissena Dutha Pratiwi, Suryanti Dwi Pudji Lestari Puteri, Rr. Astrid Aulia Artiono Putra, Andika Chandra Rebekah Setiabudi, Rebekah Resti Yudhawati Retno A Setyoningrum Retno Asih Retno Asih Setyoningrum Risnawati Risnawati Riyanto, Shandy Billy Saefudin, Rendra P. Sahrun Sahrun Santoso, Andintia Aisyah Setyawan, Ungky Agus Sita Andarini Sita Ro'yul Aini Sjahjenny Mustokoweni, Sjahjenny soedarto soedarto, soedarto Sri Melati Munir Sri Melati Munir Subagyo, Zaufy Verlieza Oktaviano Sulistiawati Sulistiawati Surya, Prima Ardiansah Susilowati Andajani, Susilowati Suwandi Syamsuri, Ibrahim Thendeyas, Richar Tomy Thirafi, Sacharissa Zerlina Tsarwah Tri Wibawa Utami Meilanie Putri Veda Septian Cahya Budi Vincent, Agustinus Wati, Farah Fatma Wibi Riawan Wiriansya, Edward Pandu Wiwin Is Effendi Yashinta, Yolanda Ayu Zahira Pelangi Rahmadilla Satriadi Zaini, Jamal Zaphiria Loka Pramesthi